Kainos Laboratories, Inc. Financial Overview
Kainos Laboratories, Inc.'s market cap is currently ¥5.19B. The company's EPS TTM is ¥29.08; its P/E ratio is 8.91; and it has a dividend yield of 2.53%. Kainos Laboratories, Inc. is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
